FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Family Planning HIV/AIDS

Contraceptive Eligibility of Women at High Risk of HIV

20 Aug 2021

The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to determine whether revisions to the fifth edition of the Medical Eligibility Criteria for contraceptive use (MEC) were needed. The issue was deemed critical in the context of women at a high lifetime risk of acquiring HIV alongside the importance of hormonal contraception in offering women and adolescent girls’ a choice and in reducing their risk of unintended pregnancy, a common threat to the health, well-being and lives of women and adolescent girls. The GDG, consisting of 28 participants from 19 countries, made recommendations on contraceptive methods used by women at high risk of HIV. These document outlines the recommendations which may be useful for policy makers. Click here to read the recommendations.  

PUBLISHED BY
World Health Organization
YEAR OF PUBLISHING
2019
AUTHORS
World Health Organization

Categories

For policymakers
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2023 Swasti Health Catalyst